Chemistry Reference
In-Depth Information
262. Gurevitch, J. et al. D-Lactic acidosis: A treatable encephalopathy in pediatric patients.
Acta Paediatr
., 82, 119, 1993.
263. Bongaerts, G. et al. Lactobacilli and acidosis in children with short small bowel.
J
Pediatr Gastroenterol Nutr.,
30, 288, 2000.
264. Codex, Codex standard for infant formula (standard 72), http://www.codexalimentarius.
net/web/more_info.jsp?id_sta=288, Codex Alimentarius Commission, 1981, revised in
1997.
265. EU, European Parliament and Council Directive No 95/2/EC of 20 February 1995 on
food additives other than colors and sweeteners, http://ec.europa.eu/food/fs/sfp/addit_
flavor/flav11_en.pdf, 1, 1995, adapted 1996, adapted 1998.
266. FAO/WHO, Toxicological evaluation of some food additives including anticaking
agents, antimicrobials, antioxidants, emulsifiers and thickening agents: Lactic acid
and its ammonium, calcium, potassium and sodium salts, http://www.inchem.org/
documents/jecfa/jecmono/v05je86.htm, Joint FAO/WHO Expert Committee on Food
Additives, WHO Fd. Add. Series, 55, 1973.
267. Connolly, E., Abrahamsson, T., and Bjorksten, B., Safety of D(-)-lactic acid producing
bacteria in the human infant.
J Pediatr Gastroenterol Nutr
., 41, 489, 2005.
268. Hol, J. et al. The acquisition of tolerance toward cow's milk through probiotic supple-
mentation: A randomized, controlled trial.
J Allergy Clin Immunol
., 121, 1448, 2008.
269. Chouraqui, J.P., Van Egroo, L.D., and Fichot, M.C. Acidified milk formula supple-
mented with
Bifidobacterium
lactis
: Impact on infant diarrhea in residential care set-
tings.
J Pediatr Gastroenterol Nutr
., 38, 288, 2004.
270. Kopp, M.V. et al. Randomized, double-blind, placebo-controlled trial of probiotics for
primary prevention: No clinical effects of
Lactobacillus
GG supplementation.
Pediatrics
,
121, 850, 2008.
271. Panigrahim, P. et al. Long-term colonization of a
Lactobacillus plantarum
synbiotic
preparation in the neonatal gut.
J Pediatr Gastroenterol Nutr
., 47, 45, 2008.
272. Taylor, A.L., Dunstan, J.A., and Prescott, S.L. Probiotic supplementation for first six
months of life fails to reduce the risk of atopic dermatitis and increases the risk of
allergen sensitization in high-risk children: A randomized controlled trial.
J Allergy Clin
Immunol.,
119, 184, 2007.
273. Taylor, A.L. et al. Foxp3 mRNA expression at 6 months of age is higher in infants who
develop atopic dermatitis, but is not affected by giving probiotics from birth.
Pediatr
Allergy Immunol
., 18, 10, 2007.
274. Taylor, A.L. et al. Effect of prebiotic supplementation for the first 6 months of life on
allergen- and vaccine-specific immune responses.
Clin Exp Allergy,
36, 1227, 2006.
275. Taylor, A.L. et al. Evaluation of the effects of probiotic supplementation from the neo-
natal period on the innate immune development in infancy.
Clin Exp Allergy,
36, 1218,
2006.
276. Rautava, S., Arvilommi, H., and Isolauri, E. Specific probiotics in enhancing maturation
of IgA responses in formula-fed infants.
Pediatr. Res
., 60, 221, 2006.
277. Ljungberg, M. et al. Probiotics for the prevention of beta cell autoimmunity in children at
genetic risk of type 1 diabetes—The Prodia study.
Ann N Y Acad. Sci
., 1079, 360, 2006.
278. Kukkonen, K. et al. Effect of probiotics on vaccine antibody responses in infancy—A
randomized placebo-controlled double-blind trial.
Pediatr Allergy Immunol
., 17, 416,
2006.
279. Brunser, O. et al. Effects of probiotic or prebiotic supplemented milk formulas on fecal
microbiota composition of infants.
Asia Pac J Clin Nutr
., 15, 368, 2006.
